Fox Business - The Power to Prosper
Search Site

Biotechnology

Can Google define the healthy human body?

Dr. Marc Siegel on Google’s ‘baseline’ health study, acetaminophen and Puma Biotechnologies’ breast cancer drug.

Read More

  1. Geopolitical stakes rise: Buy into the market?

    Hedgeye Risk Management CEO Keith McCullough and JonesTrading chief market strategist Michael O’Rourke discuss the economic impact of geopolitical events.

  2. What’s driving housing?

    Deutsche Bank senior U.S. economist Carl Riccadonna and Hightower managing director Leo Kelly discuss the state of the housing market,

  3. Fed Chair Yellen defends keeping interest rates low

    FBN’s Peter Barnes recaps Janet Yellen’s latest congressional testimony.

  4. Did Yellen go too far in market comments?

    Lido Isle Advisors Managing Partner Jason Rotman, Schaeffer’s Investment Research senior equity analyst Joe Bell and SFG Alternatives CIO Larry Shover on Federal Reserve Chairman Janet Yellen’s comments.

  5. Google appoints Alan Mulally to Board of Directors

    Claman on Call: FBN’s Liz Claman with an after-hours web exclusive on the markets, Alan Mulally’s appointment to Google’s Board of Directors and Intel and Yahoo earnings.

  6. Yellen: valuations appear 'stretched'

    FBN’s Peter Barnes reports on Fed Chair Janet Yellen’s testimony and how it impacted the market.

  7. How to play small caps

    Royce & Associated portfolio manager Bill Hench gives tips for investing in small caps.

  8. What is behind the success of specialty pharma?

    Sanford Bernstein analyst Ronny Gal on the business model of specialty pharma.

  9. What is behind the success of specialty pharma?

    Sanford Bernstein analyst Ronny Gal on the business model of specialty pharma.

  10. Is GM a ‘buy’ for your portfolio?

    Brandywine Global Managing Director Patrick Kaser, Piper Jaffray senior technical analyst Craig Johnson and Spectrum Asset Management Managing Director Michael Gurka on the markets.

  11. Tracking the hot money

    BNP Paribas head of equity cash trading Darren Wolfberg breaks down where the big-money players are investing.

  12. IPO’s raised $8B in June

    FBN’s Liz MacDonald on proceeds from IPO’s.

  1. Yellen: Social media valuations stretched

    WSJ chief economics correspondent Jon Hilsenrath on Fed chairman Janet Yellen’s comments on social media stocks and his take on the markets.

  2. Investing in InterMune worth the risk?

    FBN’s Charles Payne, Penn Financial Group founder Matt McCall and Divine Capital CEO Dani Hughes debate the outlook for InterMune.

  3. Will GM, Ford earnings beat?

    FBN’s Charles Payne, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall, FBN’s Tracy Byrnes and FOXBusiness.com reporter Kate Rogers on what should be on investors’ radar.

  4. Market check: PBYI

    FBN’s Nicole Petallides with the latest on the markets.

  5. Market check: DKS, PBYI

    FBN’s Lauren Simonetti with the latest business headlines.

  6. How to play the markets today

    Stifel Nicolaus portfolio manager Chad Morganlander and Independents co-host Matt Welch give tips for investing in today’s market.

  7. Should investors worry about bubble-rich environment?

    Hedgeye Risk Management CEO Keith McCullough and JonesTrading chief market strategist Michael O’Rourke discuss whether the markets are in bubble territory because of the Fed.

‹ Prev12345Next ›
Freebase CC-BY
Source: Biotechnology on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL